Stacey C. Sigmon, Ph.D. - Publications

Affiliations: 
University of Vermont, Burlington, VT, United States 

129 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Harfmann RF, Heil SH, Bunn JY, Snell LM, Tidey JW, Sigmon SC, Gaalema DE, Lee DC, Streck JM, Bergeria CL, Davis DR, Plucinski S, Higgins ST. Changes in weight among individuals with psychiatric conditions or socioeconomic disadvantage assigned to smoke very low nicotine content cigarettes. Experimental and Clinical Psychopharmacology. PMID 38236223 DOI: 10.1037/pha0000700  0.706
2023 Sigmon SC, Peck KR, Batchelder SR, Badger GJ, Heil SH, Higgins ST. Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials. Jama Network Open. 6: e2331910. PMID 37755833 DOI: 10.1001/jamanetworkopen.2023.31910  0.574
2023 Peck KR, Badger GJ, Cole R, Higgins ST, Moxley-Kelly N, Sigmon SC. Prolonged exposure therapy for PTSD in individuals with opioid use disorder: A randomized pilot study. Addictive Behaviors. 143: 107688. PMID 36989699 DOI: 10.1016/j.addbeh.2023.107688  0.564
2022 Browning KO, DeSarno MJ, Davis DR, Streck JM, Bergeria CL, Harfmann RF, Parker MA, Heil SH, Sigmon SC, Gaalema DE, Tidey JW, Lee DC, Tetreault HJ, Higgins ST. Relating individual differences in the reinforcing value of smoking and dependence severity to nicotine exposure levels in vulnerable populations. Preventive Medicine. 107312. PMID 36272516 DOI: 10.1016/j.ypmed.2022.107312  0.751
2022 Gaalema DE, Snell LM, Tidey JW, Sigmon SC, Heil SH, Lee DC, Bunn JY, Park C, Hughes JR, Higgins ST. Potential effects of nicotine content in cigarettes on use of other substances. Preventive Medicine. 107290. PMID 36208817 DOI: 10.1016/j.ypmed.2022.107290  0.757
2022 Higgins ST, Erath TG, DeSarno M, Reed DD, Gaalema DE, Sigmon SC, Heil SH, Tidey JW. Leveraging the cigarette purchase task to understand relationships between cumulative vulnerabilities, the relative reinforcing effects of smoking, and response to reduced nicotine content cigarettes. Preventive Medicine. 107206. PMID 35995102 DOI: 10.1016/j.ypmed.2022.107206  0.756
2022 Wiley RC, Oliver AC, Snow MB, Bunn JY, Barrows AJ, Tidey JW, Lee DC, Sigmon SC, Gaalema DE, Heil SH, Markesich C, Villanti AC, Higgins ST. The Impact of the Covid-19 Pandemic on Smoking Among Vulnerable Populations. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35605264 DOI: 10.1093/ntr/ntac135  0.74
2021 Heil SH, Melbostad HS, Matusiewicz AK, Rey CN, Badger GJ, Shepard DS, Sigmon SC, MacAfee LK, Higgins ST. Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy: A Randomized Clinical Trial. Jama Psychiatry. PMID 34259798 DOI: 10.1001/jamapsychiatry.2021.1715  0.59
2021 Heil SH, Melbostad HS, Matusiewicz AK, Rey CN, Badger GJ, Shepard DS, Sigmon SC, MacAfee LK, Higgins ST. Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy: A Randomized Clinical Trial. Jama Psychiatry. PMID 34259798 DOI: 10.1001/jamapsychiatry.2021.1715  0.59
2021 Oliver AC, DeSarno M, Irvin CG, Kaminsky D, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Lee D, Bunn JY, Davis DR, Streck JM, Gallagher T, Higgins ST. Effects of Reduced Nicotine Content Cigarettes on Fractional Exhaled Nitric Oxide (FeNO) and Self-Reported Respiratory Health Outcomes among Smokers with Psychiatric Conditions or Socioeconomic Disadvantage. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 34255068 DOI: 10.1093/ntr/ntab145  0.738
2021 Oliver AC, DeSarno M, Irvin CG, Kaminsky D, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Lee D, Bunn JY, Davis DR, Streck JM, Gallagher T, Higgins ST. Effects of Reduced Nicotine Content Cigarettes on Fractional Exhaled Nitric Oxide (FeNO) and Self-Reported Respiratory Health Outcomes among Smokers with Psychiatric Conditions or Socioeconomic Disadvantage. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 34255068 DOI: 10.1093/ntr/ntab145  0.738
2021 Higgins ST, DeSarno M, Bunn JY, Gaalema DE, Leventhal AM, Davis DR, Streck JM, Harfmann RF, Markesich C, Orr E, Sigmon SC, Heil SH, Tidey JW, Lee D, Hughes JR. Cumulative vulnerabilities as a potential moderator of response to reduced nicotine content cigarettes. Preventive Medicine. 106714. PMID 34242666 DOI: 10.1016/j.ypmed.2021.106714  0.751
2021 Higgins ST, DeSarno M, Bunn JY, Gaalema DE, Leventhal AM, Davis DR, Streck JM, Harfmann RF, Markesich C, Orr E, Sigmon SC, Heil SH, Tidey JW, Lee D, Hughes JR. Cumulative vulnerabilities as a potential moderator of response to reduced nicotine content cigarettes. Preventive Medicine. 106714. PMID 34242666 DOI: 10.1016/j.ypmed.2021.106714  0.751
2020 Higgins ST, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Lee D, Hughes JR, Villanti AC, Bunn JY, Davis DR, Bergeria CL, Streck JM, Parker MA, Miller ME, DeSarno M, et al. Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical Trials. Jama Network Open. 3: e2019311. PMID 33079196 DOI: 10.1001/jamanetworkopen.2020.19311  0.74
2020 Higgins ST, DeSarno M, Davis DR, Nighbor T, Streck JM, Adise S, Harfmann R, Nesheim-Case R, Markesich C, Reed D, Tyndale RF, Gaalema DE, Heil SH, Sigmon SC, Tidey JW, et al. Relating individual differences in nicotine dependence severity to underpinning motivational and pharmacological processes among smokers from vulnerable populations. Preventive Medicine. 106189. PMID 32628945 DOI: 10.1016/J.Ypmed.2020.106189  0.768
2020 Streck JM, Sigmon SC, Priest J, Bergeria CL, Davis DR, Hughes JR, Villanti AC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities. Experimental and Clinical Psychopharmacology. PMID 32027158 DOI: 10.1037/Pha0000350  0.794
2020 Rey CN, Badger GJ, Melbostad HS, Wachtel D, Sigmon SC, MacAfee LK, Dougherty AK, Heil SH. Perceptions of Long-Acting Reversible Contraception among Women Receiving Medication for Opioid Use Disorder in Vermont. Contraception. PMID 32014521 DOI: 10.1016/J.Contraception.2020.01.010  0.323
2020 Peck KR, Ochalek TA, Badger GJ, Sigmon SC. Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults. Drug and Alcohol Dependence. 208: 107879. PMID 31991327 DOI: 10.1016/J.Drugalcdep.2020.107879  0.361
2019 Davis DR, Miller ME, Streck JM, Bergeria CL, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Villanti AC, Stitzer ML, Priest JS, Bunn JY, Skelly JM, Diaz V, Arger CA, et al. Response to Reduced Nicotine Content in Vulnerable Populations: Effect of Menthol Status. Tobacco Regulatory Science. 5: 135-142. PMID 31890749 DOI: 10.18001/Trs.5.2.5  0.76
2019 Davis DR, Parker MA, Villanti AC, Streck JM, Priest JS, Tidey JW, Gaalema DE, Sigmon SC, Heil SH, Higgins ST. Examining Age as a Potential Moderator of Response to Reduced Nicotine Content Cigarettes in Vulnerable Populations. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S49-S55. PMID 31867655 DOI: 10.1093/Ntr/Ntz134  0.753
2019 Gaalema DE, Tidey JW, Davis DR, Sigmon SC, Heil SH, Stitzer ML, Desarno MJ, Diaz V, Hughes JR, Higgins ST. Potential Moderating Effects of Psychiatric Diagnosis and Symptom Severity on Subjective and Behavioral Responses to Reduced Nicotine Content Cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S29-S37. PMID 31867653 DOI: 10.1093/Ntr/Ntz139  0.731
2019 Gaalema DE, Dube S, Potter A, Elliott RJ, Mahoney K, Sigmon SC, Higgins ST, Ades PA. The effect of executive function on adherence with a cardiac secondary prevention program and its interaction with an incentive-based intervention. Preventive Medicine. 105865. PMID 31662210 DOI: 10.1016/J.Ypmed.2019.105865  0.596
2019 Parker MA, Sigmon SC, Villanti AC. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses. Addictive Behaviors. 99: 106112. PMID 31476691 DOI: 10.1016/J.Addbeh.2019.106112  0.462
2019 Davis DR, DeSarno MJ, Bergeria CL, Streck JM, Tidey JW, Sigmon SC, Heil SH, Gaalema DE, Stitzer ML, Higgins ST. Examining effects of unit price on preference for reduced nicotine content cigarettes and smoking rate. Preventive Medicine. 105823. PMID 31470023 DOI: 10.1016/J.Ypmed.2019.105823  0.75
2019 Sigmon SC. Innovations in efforts to expand treatment for opioid use disorder. Preventive Medicine. 105818. PMID 31445112 DOI: 10.1016/J.Ypmed.2019.105818  0.378
2019 Streck JM, Davis DR, Pang RD, Sigmon SC, Bunn JY, Bergeria CL, Tidey JW, Heil SH, Gaalema DE, Hughes JR, Stitzer ML, Reed E, Higgins ST. Potential Moderating Effects of Sex/Gender on the Acute Relative Reinforcing and Subjective Effects of Reduced Nicotine Content Cigarettes in Vulnerable Populations. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31225625 DOI: 10.1093/Ntr/Ntz098  0.749
2019 Peck KR, Parker MA, Sigmon SC. Reasons for non-medical use of prescription opioids among young adults: Role of educational status. Preventive Medicine. PMID 30951735 DOI: 10.1016/J.Ypmed.2019.03.047  0.324
2019 Bergeria CL, Heil SH, Davis DR, Streck JM, Sigmon SC, Bunn JY, Tidey JW, Arger CA, Reed DD, Gallagher T, Hughes JR, Gaalema DE, Stitzer ML, Higgins ST. Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content. Drug and Alcohol Dependence. 197: 56-64. PMID 30776572 DOI: 10.1016/J.Drugalcdep.2019.01.004  0.759
2019 Ochalek TA, Parker MA, Higgins ST, Sigmon SC. Fentanyl exposure among patients seeking opioid treatment. Journal of Substance Abuse Treatment. 96: 23-25. PMID 30466544 DOI: 10.1016/J.Jsat.2018.10.007  0.648
2018 Parker MA, Streck JM, Bergeria CL, Bunn JY, Gaalema DE, Davis DR, Barrows AJ, Sigmon SC, Tidey JW, Heil SH, Higgins ST. Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations. Tobacco Regulatory Science. 4: 84-91. PMID 30417034 DOI: 10.18001/Trs.4.5.8  0.77
2018 Streck JM, Bergeria CL, Parker MA, Davis DR, DeSarno M, Sigmon SC, Hughes JR, Gaalema DE, Heil SH, Tidey JW, Stitzer ML, Rothman M, Higgins ST. Response to reduced nicotine content cigarettes among smokers with chronic health conditions. Preventive Medicine Reports. 12: 321-329. PMID 30416951 DOI: 10.1016/J.Pmedr.2018.10.001  0.772
2018 Parker MA, Ochalek TA, Rose GL, Badger GJ, Sigmon SC. Feasibility of an interactive voice response system for daily monitoring of illicit opioid use during buprenorphine treatment. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 30359047 DOI: 10.1037/Adb0000413  0.392
2018 Ochalek TA, Heil SH, Higgins ST, Badger GJ, Sigmon SC. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study. Drug and Alcohol Dependence. 190: 224-228. PMID 30056321 DOI: 10.1016/J.Drugalcdep.2018.05.032  0.599
2018 Streck JM, Ochalek TA, Miller ME, Meyer AC, Badger G, Teneback C, Dixon A, Higgins ST, Sigmon SC. Promoting smoking abstinence among patients with chronic obstructive pulmonary disease: Initial feasibility. Preventive Medicine Reports. 11: 176-179. PMID 29992083 DOI: 10.1016/J.Pmedr.2018.06.016  0.687
2018 Streck JM, Ochalek TA, Badger GJ, Sigmon SC. Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms. Experimental and Clinical Psychopharmacology. PMID 29939049 DOI: 10.1037/Pha0000199  0.352
2018 Villanti AC, Gaalema DE, Tidey JW, Kurti AN, Sigmon SC, Higgins ST. Co-occurring vulnerabilities and menthol use in U.S. young adult cigarette smokers: Findings from Wave 1 of the PATH Study, 2013-2014. Preventive Medicine. PMID 29890187 DOI: 10.1016/J.Ypmed.2018.06.001  0.755
2018 Lofwall MR, Walsh SL, Nunes EV, Bailey GL, Sigmon SC, Kampman KM, Frost M, Tiberg F, Linden M, Sheldon B, Oosman S, Peterson S, Chen M, Kim S. Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. Jama Internal Medicine. PMID 29799968 DOI: 10.1001/Jamainternmed.2018.1052  0.372
2018 Higgins ST, Bergeria CL, Davis DR, Streck JM, Villanti AC, Hughes JR, Sigmon SC, Tidey JW, Heil SH, Gaalema DE, Stitzer ML, Priest JS, Skelly JM, Reed DD, Bunn JY, et al. Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity. Preventive Medicine. PMID 29626557 DOI: 10.1016/J.Ypmed.2018.04.010  0.774
2018 Parker MA, Streck JM, Sigmon SC. Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers. Drug and Alcohol Dependence. 186: 167-170. PMID 29579724 DOI: 10.1016/J.Drugalcdep.2018.01.024  0.524
2018 Streck JM, Heil SH, Higgins ST, Bunn JY, Sigmon SC. Tobacco Withdrawal Among Opioid-Dependent Smokers. Experimental and Clinical Psychopharmacology. PMID 29389213 DOI: 10.1037/Pha0000185  0.727
2018 Peisch V, D. Sullivan A, Breslend NL, Benoit R, Sigmon SC, Forehand GL, Strolin-Goltzman J, Forehand R. Parental Opioid Abuse: A Review of Child Outcomes, Parenting, and Parenting Interventions Journal of Child and Family Studies. 27: 2082-2099. DOI: 10.1007/S10826-018-1061-0  0.301
2017 Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST. Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content. Experimental and Clinical Psychopharmacology. 25: 473-478. PMID 29251976 DOI: 10.1037/Pha0000145  0.778
2017 Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST. Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content. Experimental and Clinical Psychopharmacology. 25: 473-478. PMID 29251976 DOI: 10.1037/pha0000145  0.411
2017 Brunette MF, Pratt SI, Bartels SJ, Scherer EA, Sigmon SC, Ferron JC, Santos M, Williams GE, Kosydar S, Wolfe RS, Lotz D, Capuchino K. Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries With Mental Illness. Psychiatric Services (Washington, D.C.). appips201700245. PMID 29137560 DOI: 10.1176/Appi.Ps.201700245  0.409
2017 Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Hughes JR, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, et al. Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction. Jama Psychiatry. PMID 28832876 DOI: 10.1001/Jamapsychiatry.2017.2355  0.738
2017 Bergeria CL, Heil SH, Bunn JY, Sigmon SC, Higgins ST. Comparing Smoking Topography and Subjective Measures of Usual Brand Cigarettes Between Pregnant and Non-Pregnant Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 28658941 DOI: 10.1093/Ntr/Ntx148  0.683
2017 Hughes JR, Callas PW, Priest JS, Etter JF, Budney AJ, Sigmon SC. Development of a Self-Report Measure of Reward Sensitivity:A Test in Current and Former Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 19: 723-728. PMID 28486712 DOI: 10.1093/Ntr/Ntw272  0.328
2017 Hughes JR, Budney AJ, Muellers SR, Lee DC, Callas PW, Sigmon SC, Fingar JR, Priest J. Does Tobacco Abstinence Decrease Reward Sensitivity? A Human Laboratory Test. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 19: 677-685. PMID 28486707 DOI: 10.1093/Ntr/Ntw204  0.337
2017 Brooklyn JR, Sigmon SC. Vermont Hub-and-Spoke Model of Care For Opioid Use Disorder: Development, Implementation, and Impact. Journal of Addiction Medicine. PMID 28379862 DOI: 10.1097/Adm.0000000000000310  0.372
2017 Sigmon SC, Schwartz RP, Higgins ST. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence. The New England Journal of Medicine. 376: 1000-1001. PMID 28273017 DOI: 10.1056/NEJMc1700539  0.591
2017 Sigmon SC, Ochalek TA, Hruska B, Heil SH, Higgins S, Rose G, Moore BA. Interim buprenorphine treatment for reducing illicit opioid use during treatment delays Drug and Alcohol Dependence. 171: e190-e191. DOI: 10.1016/J.Drugalcdep.2016.08.522  0.631
2017 Ochalek TA, Pusey JD, Hruska B, Heil SH, Higgins S, Rose G, Moore BA, Sigmon SC. Within-subject evaluation of interim buprenorphine vs. waitlist on illicit opioid use Drug and Alcohol Dependence. 171: e154. DOI: 10.1016/J.Drugalcdep.2016.08.426  0.629
2017 Bergeria CL, Heil SH, Sigmon SC, Durand H, Higgins S. Comparing smoking topography of usual brand cigarettes in pregnant and non-pregnant women Drug and Alcohol Dependence. 171: e19. DOI: 10.1016/J.Drugalcdep.2016.08.067  0.661
2017 Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer M, Gaalema D, Desarno M, Durand H, Ruggieri E, Higgins S. Validity of the modified cigarette evaluation questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content under double-blind conditions Drug and Alcohol Dependence. 171: e10. DOI: 10.1016/J.Drugalcdep.2016.08.042  0.744
2016 Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST. Interim Buprenorphine vs. Waiting List for Opioid Dependence. The New England Journal of Medicine. 375: 2504-2505. PMID 28002704 DOI: 10.1056/Nejmc1610047  0.639
2016 Sigmon SC. Additive burdens of malnutrition, poverty, and substance abuse. Lancet (London, England). 388: 1879-1880. PMID 27751393 DOI: 10.1016/S0140-6736(16)31814-1  0.301
2016 Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, et al. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology. PMID 27714427 DOI: 10.1007/S00213-016-4438-Z  0.755
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting. Journal of Substance Abuse Treatment. 71: 1-7. PMID 27672239 DOI: 10.1016/J.Jsat.2016.08.006  0.741
2016 Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug and Alcohol Dependence. 168: 69-75. PMID 27615403 DOI: 10.1016/J.Drugalcdep.2016.07.032  0.719
2016 Sigmon SC, Bigelow GE. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential. Addiction (Abingdon, England). PMID 27561982 DOI: 10.1111/Add.13539  0.326
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Sigmon SC, Fingerhood M, Bigelow GE. Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids. Journal of Addiction Medicine. PMID 27504923 DOI: 10.1097/Adm.0000000000000235  0.739
2016 Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. Journal of Substance Abuse Treatment. PMID 27394070 DOI: 10.1016/J.Jsat.2016.06.009  0.61
2016 Heil SH, Hand DJ, Sigmon SC, Badger GJ, Meyer MC, Higgins ST. Using Behavioral Economic Theory to Increase Use of Effective Contraceptives among Opioid-maintained Women at Risk of Unintended Pregnancy. Preventive Medicine. PMID 27346756 DOI: 10.1016/J.Ypmed.2016.06.023  0.627
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting Journal of Substance Abuse Treatment. 71: 1-7. DOI: 10.1016/j.jsat.2016.08.006  0.732
2016 Heil S, Matusiewicz A, Melbostad H, Sigmon S, Meyer M, Higgins S. Increasing effective contraceptive use among opioid-maintained women at risk for unintended pregnancy Contraception. 94: 403-404. DOI: 10.1016/J.Contraception.2016.07.081  0.611
2015 Sigmon SC, Miller ME, Meyer AC, Saulsgiver K, Badger GJ, Heil SH, Higgins ST. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial. Addiction (Abingdon, England). PMID 26638126 DOI: 10.1111/Add.13264  0.719
2015 Sigmon SC, C Meyer A, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP. Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility. Addictive Behaviors. 51: 136-42. PMID 26256469 DOI: 10.1016/J.Addbeh.2015.07.030  0.659
2015 Miller ME, Sigmon SC. Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 17: 955-9. PMID 26180219 DOI: 10.1093/Ntr/Ntv030  0.536
2015 Sigmon SC. Interim treatment: Bridging delays to opioid treatment access. Preventive Medicine. 80: 32-6. PMID 25937593 DOI: 10.1016/J.Ypmed.2015.04.017  0.388
2015 Miller ME, Badger GJ, Heil SH, Higgins ST, Sigmon SC. Associations between sensation seeking and d-amphetamine reinforcement. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 25846715 DOI: 10.1111/Ajad.12226  0.582
2015 Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug and Alcohol Dependence. 151: 47-55. PMID 25823907 DOI: 10.1016/J.Drugalcdep.2015.02.033  0.607
2015 Meyer AC, Miller ME, Sigmon SC. Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers. Addictive Behaviors. 42: 189-93. PMID 25481453 DOI: 10.1016/J.Addbeh.2014.11.006  0.368
2015 Miller ME, Sigmon SC. Are pharmacotherapies ineffective in opioid-dependent smokers? Reflections on the scientific literature and future directions Nicotine and Tobacco Research. 17: 955-959. DOI: 10.1093/ntr/ntv030  0.321
2015 Streck JM, Meyer AC, Bunn J, Sigmon SC. Characterizing nicotine withdrawal in opioid-maintained smokers Drug and Alcohol Dependence. 156: e213-e214. DOI: 10.1016/J.Drugalcdep.2015.07.576  0.476
2015 Sigmon SC, Meyer AC, Hruska B, Ochalek T, Heil SH, Higgins ST, Schwartz RP. Interim buprenorphine treatment: Leveraging technology to bridge waitlist delays Drug and Alcohol Dependence. 156: e204. DOI: 10.1016/J.Drugalcdep.2015.07.550  0.559
2015 Ochalek TA, Meyer AC, Hruska B, Streck JM, Sigmon SC. An m Health application for increasing HIV and hepatitis knowledge in waitlisted opioid abusers Drug and Alcohol Dependence. 156: e166. DOI: 10.1016/J.Drugalcdep.2015.07.451  0.307
2015 Meyer AC, Streck JM, Ochalek TA, Hruska B, Teneback CC, Dixon AE, Sigmon SC. Financial incentives promote smoking abstinence among patients with pulmonary disease Drug and Alcohol Dependence. 156: e150-e151. DOI: 10.1016/J.Drugalcdep.2015.07.410  0.387
2015 Hruska B, Meyer AC, Sigmon SC. Smoking status on day 3 of a quit attempt predicts future smoking outcomes Drug and Alcohol Dependence. 156: e98-e99. DOI: 10.1016/J.Drugalcdep.2015.07.1185  0.436
2015 Patrick ME, Meyer AC, Higgins ST, Sigmon SC. Influence of sensation seeking on d-amphetamine reinforcement Drug and Alcohol Dependence. 146: e64-e65. DOI: 10.1016/J.Drugalcdep.2014.09.544  0.552
2015 Meyer AC, Patrick ME, Heil SH, Higgins ST, Sigmon SC. Gender differences in smoking and treatment outcome among opioid-maintained smokers Drug and Alcohol Dependence. 146: e39. DOI: 10.1016/J.Drugalcdep.2014.09.478  0.705
2015 Hand J, Heil S, Sigmon S, Higgins S. Cigarette smoking and other behavioral risk factors related to unintended pregnancy Drug and Alcohol Dependence. 146: e134. DOI: 10.1016/J.Drugalcdep.2014.09.282  0.615
2015 Bergeria CL, Hand D, Meyer M, Higgins ST, Sigmon SC, Heil SH. Characterizing interpregnancy intervals of opioid-maintained women Drug and Alcohol Dependence. 146: e222. DOI: 10.1016/J.Drugalcdep.2014.09.072  0.607
2015 Sigmon SC, Meyer AC, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP. Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility Addictive Behaviors. 51: 136-142. DOI: 10.1016/j.addbeh.2015.07.030  0.535
2014 Sigmon SC, Kennedy AG. The prescription opioid abuse epidemic in rural America: a look at how it begins Journal of Opioid Management. 10: 225-226. PMID 25162602 DOI: 10.5055/Jom.2014.0210  0.367
2014 Patrick ME, Dunn KE, Badger GJ, Heil SH, Higgins ST, Sigmon SC. Spontaneous reductions in smoking during double-blind buprenorphine detoxification. Addictive Behaviors. 39: 1353-6. PMID 24845165 DOI: 10.1016/J.Addbeh.2014.04.023  0.79
2014 Hand DJ, Heil SH, Sigmon SC, Higgins ST. Improving medicaid health incentives programs: lessons from substance abuse treatment research. Preventive Medicine. 63: 87-9. PMID 24613792 DOI: 10.1016/J.Ypmed.2014.03.001  0.624
2014 Sigmon SC. Access to treatment for opioid dependence in rural america: Challenges and future directions Jama Psychiatry. 71: 359-360. PMID 24500040 DOI: 10.1001/Jamapsychiatry.2013.4450  0.363
2014 Sigmon SC, Patrick ME, Meyer AC, Teneback C, Dixon A. Financial incentives for smoking abstinence in patients diagnosed with pulmonary disease Drug and Alcohol Dependence. 140: e208. DOI: 10.1016/J.Drugalcdep.2014.02.578  0.479
2014 Patrick ME, Sigmon SC, Meyer AC, Heil SH, Higgins ST. Influence of bupropion on smoking abstinence in opioid-maintained smokers Drug and Alcohol Dependence. 140: e170. DOI: 10.1016/J.Drugalcdep.2014.02.478  0.712
2014 Meyer AC, Sigmon SC, Patrick ME, Heil SH, Higgins ST. Characterizing prescription opioid abusers with and without lifetime heroin use Drug and Alcohol Dependence. 140: e148. DOI: 10.1016/J.Drugalcdep.2014.02.420  0.637
2014 Heil SH, Hand D, Sigmon SC, Meyer M, HIggins ST. Improving effective contraceptive use among opioid-maintained women Drug and Alcohol Dependence. 140: e84. DOI: 10.1016/J.Drugalcdep.2014.02.248  0.618
2013 Sigmon SC, Dunn KE, Saulsgiver K, Patrick ME, Badger GJ, Heil SH, Brooklyn JR, Higgins ST. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. Jama Psychiatry. 70: 1347-54. PMID 24153411 DOI: 10.1001/Jamapsychiatry.2013.2216  0.725
2013 Dunn KE, Saulsgiver KA, Patrick ME, Heil SH, Higgins ST, Sigmon SC. Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers. Drug and Alcohol Dependence. 133: 625-32. PMID 24051063 DOI: 10.1016/J.Drugalcdep.2013.08.007  0.69
2013 Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL. Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction (Abingdon, England). 108: 2141-9. PMID 23919595 DOI: 10.1111/Add.12315  0.323
2013 Herrmann ES, Heil SH, Sigmon SC, Dunn KE, Washio Y, Higgins ST. Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients using modified materials. Drug and Alcohol Dependence. 127: 220-5. PMID 22889696 DOI: 10.1016/J.Drugalcdep.2012.07.006  0.688
2012 Heil SH, Gaalema DE, Johnston AM, Sigmon SC, Badger GJ, Higgins ST. Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: a feasibility study. Drug and Alcohol Dependence. 126: 268-71. PMID 22682657 DOI: 10.1016/J.Drugalcdep.2012.05.006  0.615
2012 Higgins ST, Silverman K, Sigmon SC, Naito NA. Incentives and health: an introduction. Preventive Medicine. 55: S2-6. PMID 22554884 DOI: 10.1016/J.Ypmed.2012.04.008  0.678
2012 Sigmon SC, Patrick ME. The use of financial incentives in promoting smoking cessation Preventive Medicine. 55: S24-S32. PMID 22525802 DOI: 10.1016/J.Ypmed.2012.04.007  0.485
2012 Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. The American Journal of Drug and Alcohol Abuse. 38: 187-99. PMID 22404717 DOI: 10.3109/00952990.2011.653426  0.382
2012 Heil S, Sigmon S, Meyer M, Higgins S. Improving effective contraceptive use among drug-dependent women: a feasibility study Contraception. 86: 308. DOI: 10.1016/J.Contraception.2012.05.086  0.583
2011 Dunn KE, Sigmon SC, Strain EC, Heil SH, Higgins ST. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug and Alcohol Dependence. 119: 1-9. PMID 21741781 DOI: 10.1016/J.Drugalcdep.2011.05.033  0.709
2011 Sigmon SC, Griffiths RR. Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine. Drug and Alcohol Dependence. 118: 341-8. PMID 21600707 DOI: 10.1016/J.Drugalcdep.2011.04.018  0.587
2011 Dunn KE, Saulsgiver KA, Sigmon SC. Contingency Management for Behavior Change: Applications to Promote Brief Smoking Cessation Among Opioid-Maintained Patients Experimental and Clinical Psychopharmacology. 19: 20-30. PMID 21341920 DOI: 10.1037/A0022039  0.686
2010 Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Experimental and Clinical Psychopharmacology. 18: 37-50. PMID 20158293 DOI: 10.1037/A0018649  0.775
2009 Dunn KE, Sigmon SC, Reimann E, Heil SH, Higgins ST. Effects of Smoking Cessation on Illicit Drug Use among Opioid Maintenance Patients: A Pilot Study. Journal of Drug Issues. 39: 313-328. PMID 20401340 DOI: 10.1177/002204260903900205  0.781
2009 Sigmon SC, Herning RI, Better W, Cadet JL, Griffiths RR. Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects. Psychopharmacology. 204: 573-85. PMID 19241060 DOI: 10.1007/S00213-009-1489-4  0.565
2009 Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST. Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addictive Behaviors. 34: 304-11. PMID 19081679 DOI: 10.1016/J.Addbeh.2008.11.017  0.736
2009 Dunn KE, Sigmon SC, Reimann E, Heil SH, Higgins ST. Effects of smoking cessation on illicit drug use among opioid maintenance patients: A pilot study Journal of Drug Issues. 39: 313-328.  0.759
2008 Dunn KE, Sigmon SC, Thomas CS, Heil SH, Higgins ST. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. Journal of Applied Behavior Analysis. 41: 527-38. PMID 19192857 DOI: 10.1901/Jaba.2008.41-527  0.766
2008 Heil SH, Sigmon SC, Jones HE, Wagner M. Comparison of characteristics of opioid-using pregnant women in rural and urban settings American Journal of Drug and Alcohol Abuse. 34: 463-471. PMID 18584576 DOI: 10.1080/00952990802122358  0.348
2008 Dunn KE, Sigmon SC, McGee MR, Heil SH, Higgins ST. Evaluation of ongoing oxycodone abuse among methadone-maintained patients. Journal of Substance Abuse Treatment. 35: 451-6. PMID 18295434 DOI: 10.1016/J.Jsat.2007.12.006  0.725
2007 Sigmon SC. Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement Experimental and Clinical Psychopharmacology. 15: 1-20. PMID 17295581 DOI: 10.1037/1064-1297.15.1.1  0.306
2007 Higgins ST, Heil SH, Sigmon SC. A behavioral approach to the treatment of substance use disorders Functional Analysis in Clinical Treatment. 261-282. DOI: 10.1016/B978-012372544-8/50015-X  0.545
2006 Sigmon SC. Characterizing the emerging population of prescription opioid abusers American Journal On Addictions. 15: 208-212. PMID 16923666 DOI: 10.1080/10550490600625624  0.395
2006 Sigmon SC, Higgins ST. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. Journal of Substance Abuse Treatment. 30: 291-5. PMID 16716843 DOI: 10.1016/J.Jsat.2006.02.001  0.607
2006 Sigmon SC, Moody DE, Nuwayser ES, Bigelow GE. An injection depot formulation of buprenorphine: Extended biodelivery and effects Addiction. 101: 420-432. PMID 16499515 DOI: 10.1111/J.1360-0443.2006.01348.X  0.359
2006 Budney AJ, Moore BA, Sigmon SC, Higgins ST. Contingency-management interventions for cannabis dependence Cannabis Dependence: Its Nature, Consequences, and Treatment. 154-176. DOI: 10.1017/CBO9780511544248.009  0.521
2005 Correia CJ, Sigmon SC, Silverman K, Bigelow G, Stitzer ML. A comparison of voucher-delivery schedules for the initiation of cocaine abstinence. Experimental and Clinical Psychopharmacology. 13: 253-8. PMID 16173889 DOI: 10.1037/1064-1297.13.3.253  0.553
2005 Heil SH, Sigmon SC, Mongeon JA, Higgins ST. Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 13: 238-43. PMID 16173887 DOI: 10.1037/1064-1297.13.3.238  0.58
2004 Sigmon SC, Correia CJ, Stitzer ML. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement. Experimental and Clinical Psychopharmacology. 12: 269-75. PMID 15571444 DOI: 10.1037/1064-1297.12.4.269  0.304
2004 Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE. Evaluation of an injection depot formulation of buprenorphine: Placebo comparison Addiction. 99: 1439-1449. PMID 15500597 DOI: 10.1111/J.1360-0443.2004.00834.X  0.407
2004 Wong CJ, Anthony S, Sigmon SC, Mongeon JA, Badger GJ, Higgins ST. Examining interrelationships between abstinence and coping self-efficacy in cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 12: 190-9. PMID 15301636 DOI: 10.1037/1064-1297.12.3.190  0.603
2004 Sobel BFX, Sigmon SC, Griffiths RR. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers Neuropsychopharmacology. 29: 991-1003. PMID 15010695 DOI: 10.1038/Sj.Npp.1300415  0.63
2004 Sobel BF, Sigmon SC, Walsh SL, Johnson RE, Liebson IA, Nuwayser ES, Kerrigan JH, Bigelow GE. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. Drug and Alcohol Dependence. 73: 11-22. PMID 14687955 DOI: 10.1016/J.Drugalcdep.2003.08.006  0.396
2003 Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, Dantona RL, Anthony S. Community reinforcement therapy for cocaine-dependent outpatients. Archives of General Psychiatry. 60: 1043-52. PMID 14557150 DOI: 10.1001/Archpsyc.60.9.1043  0.604
2003 Sigmon SC, Tidey JW, Badger GJ, Higgins ST. Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money. Psychopharmacology. 167: 393-402. PMID 12684732 DOI: 10.1007/S00213-003-1416-Z  0.743
2002 Wong CJ, Badger GJ, Sigmon SC, Higgins ST. Examining possible gender differences among cocaine-dependent outpatients. Experimental and Clinical Psychopharmacology. 10: 316-23. PMID 12233993 DOI: 10.1037//1064-1297.10.3.316  0.598
2000 Sigmon SC, Steingard S, Badger GJ, Anthony SL, Higgins ST. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Experimental and Clinical Psychopharmacology. 8: 509-17. PMID 11127422 DOI: 10.1037/1064-1297.8.4.509  0.598
2000 Higgins ST, Sigmon SC. Implications of behavioral momentum for understanding the behavioral pharmacology of abused drugs Behavioral and Brain Sciences. 23: 101-101. DOI: 10.1017/S0140525X0033240X  0.575
Show low-probability matches.